Table of Contents

Executive Summary

1 Industry Overview of Gabapentin Drug

• 1.1 Definition of Gabapentin Drug
• 1.2 Gabapentin Drug Segment by Type
  • 1.2.1 Global Gabapentin Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Capsule
  • 1.2.3 Tablet
  • 1.2.4 Oral solution
• 1.3 Gabapentin Drug Segment by Applications
  • 1.3.1 Global Gabapentin Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Postherpetic neuralgia in adults
  • 1.3.3 Partial onset seizures
  • 1.3.4 Others
• 1.4 Global Gabapentin Drug Overall Market
  • 1.4.1 Global Gabapentin Drug Revenue (2014-2025)
  • 1.4.2 Global Gabapentin Drug Production (2014-2025)
  • 1.4.3 North America Gabapentin Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Gabapentin Drug Status and Prospect (2014-2025)
  • 1.4.5 China Gabapentin Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Gabapentin Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Gabapentin Drug Status and Prospect (2014-2025)
  • 1.4.8 India Gabapentin Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Gabapentin Drug
• 2.3 Manufacturing Process Analysis of Gabapentin Drug
• 2.4 Industry Chain Structure of Gabapentin Drug

3 Development and Manufacturing Plants Analysis of Gabapentin Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Gabapentin Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Gabapentin Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Gabapentin Drug Production and Capacity Analysis
• 4.2 Gabapentin Drug Revenue Analysis
• 4.3 Gabapentin Drug Price Analysis
• 4.4 Market Concentration Degree

5 Gabapentin Drug Regional Market Analysis

• 5.1 Gabapentin Drug Production by Regions
  • 5.1.1 Global Gabapentin Drug Production by Regions
  • 5.1.2 Global Gabapentin Drug Revenue by Regions
• 5.2 Gabapentin Drug Consumption by Regions
• 5.3 North America Gabapentin Drug Market Analysis
  • 5.3.1 North America Gabapentin Drug Production
  • 5.3.2 North America Gabapentin Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Gabapentin Drug Import and Export
• 5.4 Europe Gabapentin Drug Market Analysis
  • 5.4.1 Europe Gabapentin Drug Production
  • 5.4.2 Europe Gabapentin Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Gabapentin Drug Import and Export
• 5.5 China Gabapentin Drug Market Analysis
  • 5.5.1 China Gabapentin Drug Production
  • 5.5.2 China Gabapentin Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Gabapentin Drug Import and Export
• 5.6 Japan Gabapentin Drug Market Analysis
  • 5.6.1 Japan Gabapentin Drug Production
  • 5.6.2 Japan Gabapentin Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Gabapentin Drug Import and Export
• 5.7 Southeast Asia Gabapentin Drug Market Analysis
  • 5.7.1 Southeast Asia Gabapentin Drug Production
  • 5.7.2 Southeast Asia Gabapentin Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Gabapentin Drug Import and Export
• 5.8 India Gabapentin Drug Market Analysis
  • 5.8.1 India Gabapentin Drug Production
  • 5.8.2 India Gabapentin Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Gabapentin Drug Import and Export

6 Gabapentin Drug Segment Market Analysis (by Type)

• 6.1 Global Gabapentin Drug Production by Type
• 6.2 Global Gabapentin Drug Revenue by Type
• 6.3 Gabapentin Drug Price by Type

7 Gabapentin Drug Segment Market Analysis (by Application)

• 7.1 Global Gabapentin Drug Consumption by Application
• 7.2 Global Gabapentin Drug Consumption Market Share by Application (2014-2019)

8 Gabapentin Drug Major Manufacturers Analysis

• 8.1 Pfizer
  • 8.1.1 Pfizer Gabapentin Drug Production Sites and Area Served
  • 8.1.2 Pfizer Product Introduction, Application and Specification
  • 8.1.3 Pfizer Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Depomed
  • 8.2.1 Depomed Gabapentin Drug Production Sites and Area Served
  • 8.2.2 Depomed Product Introduction, Application and Specification
  • 8.2.3 Depomed Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Apotex
  • 8.3.1 Apotex Gabapentin Drug Production Sites and Area Served
  • 8.3.2 Apotex Product Introduction, Application and Specification
  • 8.3.3 Apotex Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Teva
  • 8.4.1 Teva Gabapentin Drug Production Sites and Area Served
  • 8.4.2 Teva Product Introduction, Application and Specification
  • 8.4.3 Teva Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Acella Pharmaceuticals
  • 8.5.1 Acella Pharmaceuticals Gabapentin Drug Production Sites and Area Served
  • 8.5.2 Acella Pharmaceuticals Product Introduction, Application and Specification
  • 8.5.3 Acella Pharmaceuticals Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Taro
  • 8.6.1 Taro Gabapentin Drug Production Sites and Area Served
  • 8.6.2 Taro Product Introduction, Application and Specification
  • 8.6.3 Taro Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Sun Pharmaceutical
  • 8.7.1 Sun Pharmaceutical Gabapentin Drug Production Sites and Area Served
  • 8.7.2 Sun Pharmaceutical Product Introduction, Application and Specification
  • 8.7.3 Sun Pharmaceutical Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Glenmark
  • 8.8.1 Glenmark Gabapentin Drug Production Sites and Area Served
  • 8.8.2 Glenmark Product Introduction, Application and Specification
  • 8.8.3 Glenmark Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Amneal Pharmaceuticals
  • 8.9.1 Amneal Pharmaceuticals Gabapentin Drug Production Sites and Area Served
  • 8.9.2 Amneal Pharmaceuticals Product Introduction, Application and Specification
  • 8.9.3 Amneal Pharmaceuticals Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Aurobindo Pharma
  • 8.10.1 Aurobindo Pharma Gabapentin Drug Production Sites and Area Served
  • 8.10.2 Aurobindo Pharma Product Introduction, Application and Specification
  • 8.10.3 Aurobindo Pharma Gabapentin Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Zydus Pharmaceuticals
• 8.12 Hi-Tech Pharmaceuticals
• 8.13 Marksans Pharma
• 8.14 Mylan
• 8.15 InvaGen Pharmaceuticals
• 8.16 Alkem Laboratories
• 8.17 Tris Pharma
• 8.18 ACI HealthCare Limited
• 8.19 Jiangsu Hengrui Medicine
• 8.20 CSPC Ouyi Pharmaceutical
• 8.21 Sciegen Pharmaceuticals
• 8.22 Epic Pharma
• 8.23 Lupin Limited

9 Development Trend of Analysis of Gabapentin Drug Market

• 9.1 Global Gabapentin Drug Market Trend Analysis
  • 9.1.1 Global Gabapentin Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Gabapentin Drug Regional Market Trend
  • 9.2.1 North America Gabapentin Drug Forecast 2019-2025
  • 9.2.2 Europe Gabapentin Drug Forecast 2019-2025
  • 9.2.3 China Gabapentin Drug Forecast 2019-2025
  • 9.2.4 Japan Gabapentin Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Gabapentin Drug Forecast 2019-2025
  • 9.2.6 India Gabapentin Drug Forecast 2019-2025
• 9.3 Gabapentin Drug Market Trend (Product Type)
• 9.4 Gabapentin Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Gabapentin Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Gabapentin (sold under the brand name Neurontin, among others) is a medication which is used to treat partial seizures, neuropathic pain, hot flashes, and restless legs syndrome. It is recommended as one of a number of first-line medications for the treatment of neuropathic pain caused by diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain. About 15% of those given gabapentin for diabetic neuropathy or postherpetic neuralgia have a measurable benefit. Gabapentin is taken by mouth.

The global Gabapentin Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Gabapentin Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gabapentin Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gabapentin Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gabapentin Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Depomed
Apotex
Teva
Acella Pharmaceuticals
Taro
Sun Pharmaceutical
Glenmark
Amneal Pharmaceuticals
Aurobindo Pharma
Zydus Pharmaceuticals
Hi-Tech Pharmaceuticals
Marksans Pharma
Mylan
InvaGen Pharmaceuticals
Alkem Laboratories
Tris Pharma
ACI HealthCare Limited
Jiangsu Hengrui Medicine
CSPC Ouyi Pharmaceutical
Sciegen Pharmaceuticals
Epic Pharma
Lupin Limited

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Capsule
Tablet
Oral solution

Segment by Application
Postherpetic neuralgia in adults
Partial onset seizures
Others